Skip to main content
  • About
  • Contact
  • Disclaimer
  • Privacy Policy
  • Terms of Service
  • Account
Ticker Report logo
  • Home
  • Finance
  • Aerospace & Defense
  • Energy
  • Pharmaceuticals
  • Technology
  • About
  • Contact
  • Disclaimer
  • Privacy Policy
  • Terms of Service
  • Account
Ticker Report logo
  • Home
  • Finance
  • Aerospace & Defense
  • Energy
  • Pharmaceuticals
  • Technology

UBI Banca’s “Underperform” Rating Reaffirmed at Credit Suisse (UBI)

Posted by Max Byerly on Jun 10th, 2013

Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits

UBI Banca logoCredit Suisse reaffirmed their underperform rating on shares of UBI Banca (EU: UBI) in a report issued on Thursday, Analyst Ratings Network reports. They currently have a €3.00 ($3.90) target price on the stock.

« PREVIOUS HEADLINE

Linde Aktiengesellschaft Rating Reiterated by Sanford C. Bernstein (LIN)

NEXT HEADLINE »

AEP Industries (AEPI) Posts Quarterly Earnings Results, Misses Estimates By $1.18 EPS

You might be interested in:

Rollins, Inc.  – What Are Analysts Saying About This Stock?
Rollins, Inc. – What Are Analysts Saying About This Stock?
First Commonwealth Financial Corporation  – What Are Researchers Saying About This Stock?
First Commonwealth Financial Corporation – What Are Researchers Saying About This Stock?
Neurocrine Biosciences  Price Target Raised to $185.00
Neurocrine Biosciences Price Target Raised to $185.00
Ichor  Stock Gets Price Target Trim from B. Riley Financial
Ichor Stock Gets Price Target Trim from B. Riley Financial
Iovance Biotherapeutics  Price Target Raised to $8.00
Iovance Biotherapeutics Price Target Raised to $8.00
Slide Insurance Holdings, Inc.  – What Are Brokerages Saying About This Stock?
Slide Insurance Holdings, Inc. – What Are Brokerages Saying About This Stock?

Daily Ratings & News for UBI Banca

Complete the form below to receive the latest headlines and analysts' recommendations for UBI Banca with MarketBeat's free daily email newsletter:

Follow @TickerReport

Recent News

  • Rollins, Inc. (ROL) – What Are Analysts Saying About This Stock?
  • First Commonwealth Financial Corporation (FCF) – What Are Researchers Saying About This Stock?
  • Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $185.00
  • Ichor (NASDAQ:ICHR) Stock Gets Price Target Trim from B. Riley Financial
  • Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Raised to $8.00
  • Slide Insurance Holdings, Inc. (SLDE) – What Are Brokerages Saying About This Stock?
  • Stella-Jones Inc. (TSE:SJ) Stock Has Average Price Target of C$89.62 According to Brokerages
  • Alpine Income Property Trust (NYSE:PINE) Stock Gets Price Target Cut from Truist Financial
  • Oaktree Specialty Lending Corp. (OCSL) – What Are Brokerages Thinking About This Stock?
  • Cipher Mining (NASDAQ:CIFR) Stock Gets Price Target Reduction from JPMorgan Chase & Co.
  • Zillow Group (NASDAQ:ZG) Stock Gets Price Target Trim from Royal Bank Of Canada
  • Marvell Technology (NASDAQ:MRVL) Cut to “Hold” at TD Cowen
  • Upstart (NASDAQ:UPST) Stock Gets Price Target Trim from Needham & Company LLC
  • Fate Therapeutics, Inc. (NASDAQ:FATE) Stock Has Average Target Price of $5.90
  • Huntington Ingalls Industries (NYSE:HII) Price Target Raised to $352.00
  • Ero Copper (NYSE:ERO) Upgraded at Scotiabank
  • CRISPR Therapeutics AG (NASDAQ:CRSP) Stock Has Average Price Target of $65.75 According to Analysts
  • Penumbra, Inc. (NYSE:PEN) Stock Has Average Target Price of $367.07 According to Analysts
  • Estee Lauder Companies (NYSE:EL) Price Target Raised to $126.00
  • Federated Hermes (NYSE:FHI) Price Target Raised to $63.00
  • Home
  • Finance
  • Aerospace & Defense
  • Energy
  • Pharmaceuticals
  • Technology
© 2012-2026 Ticker Report
MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103
Email: trcontact [at] tickerreport [dot] com
Phone: (844) 978-6257

Ticker Report members receive the latest stock market news and a concise summary of new analysts' recommendations in a FREE daily email newsletter. Manage your account here.

Sign Up With Google